Proteus

Also: Centauri Health Solutions acquires HCFS; UCSF researchers detail smartphone PPG-based diabetes detection.

This week's top stories include the Department of Health and Human Services whittling down coronavirus vaccine candidates, the Senate looking at telehealth's future and Proteus Digital Health filing for bankruptcy.

The news comes months after reports that the company had furloughed staff and couldn't secure additional funding for its-ingestible sensor business.

The industry is better off viewing the the floundering deals between Onduo and Sanofi, Proteus and Otsuka, and Pear and Sandoz as a learning opportunity.

News of the ID-Cap System's 510(k) comes amidst reports of turmoil within the business of its predecessor in clearance, Proteus Digital Health.

The digital pill maker's employees were brought back after the company secured $5 million in emergency funding, but CNBC's report suggests that several are now looking elsewhere for work.

The multi-center, single-arm, open-label study recorded an overall medication adherence rate of 93% alongside strong treatment outcomes.

The independent investigation suggests that wirelessly observed therapies using Proteus' system could be considered equivalent to in-person medication adherence programs, but much better received by patients taking oral medications.

The sensor-embedded pill will be used to treat and monitor colorectal cancer patients receiving care at Fairview Health Services.

As the Abilify MyCite platform nears a full rollout, the companies said they are looking forward to employing the technology toward additional mental health therapies.